BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12782606)

  • 1. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
    Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
    Rassidakis GZ; Claret FX; Lai R; Zhang Q; Sarris AH; McDonnell TJ; Medeiros LJ
    Clin Cancer Res; 2003 Mar; 9(3):1121-8. PubMed ID: 12631617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasin interacts with Jab1 and influences breast cancer progression.
    Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
    Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A
    J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.